Topotecan versus paclitaxel in second-line therapy: A lost opportunity for quality-of-life evaluation? (multiple letter) [1]

G. Apolone; A. Buda; Graham A. Ross; J. A. Kettels

doi:10.1093/annonc/mdh357

Topotecan versus paclitaxel in second-line therapy: A lost opportunity for quality-of-life evaluation? (multiple letter) [1]

G. Apolone, A. Buda, Graham A. Ross, J. A. Kettels

Arcispedale Santa Maria Nuova

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	1443-1444
Number of pages	2
Journal	Annals of Oncology
Volume	15
Issue number	9
DOIs	https://doi.org/10.1093/annonc/mdh357
Publication status	Published - Sep 2004

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.1093/annonc/mdh357

Cite this

Apolone, G., Buda, A., Ross, G. A., & Kettels, J. A. (2004). Topotecan versus paclitaxel in second-line therapy: A lost opportunity for quality-of-life evaluation? (multiple letter) [1]. Annals of Oncology, 15(9), 1443-1444. https://doi.org/10.1093/annonc/mdh357

@article{401c0c5d12fa4de2ae12211abebf1daf,

title = "Topotecan versus paclitaxel in second-line therapy: A lost opportunity for quality-of-life evaluation? (multiple letter) [1]",

author = "G. Apolone and A. Buda and Ross, {Graham A.} and Kettels, {J. A.}",

year = "2004",

month = sep,

doi = "10.1093/annonc/mdh357",

language = "English",

volume = "15",

pages = "1443--1444",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "9",

}

TY - JOUR

T1 - Topotecan versus paclitaxel in second-line therapy

T2 - A lost opportunity for quality-of-life evaluation? (multiple letter) [1]

AU - Apolone, G.

AU - Buda, A.

AU - Ross, Graham A.

AU - Kettels, J. A.

PY - 2004/9

Y1 - 2004/9

UR - http://www.scopus.com/inward/record.url?scp=4644364705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644364705&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdh357

DO - 10.1093/annonc/mdh357

M3 - Article

C2 - 15319253

AN - SCOPUS:4644364705

VL - 15

SP - 1443

EP - 1444

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 9

ER -